News‘Nanodecoy’ therapy binds and neutralizes SARS-CoV-2
virus

17th June 2021by admin0
https://nfusion-tech.com/wp-content/uploads/2021/06/nanodecoy-therapy-binds-and-neutralizes-sars-cov-2virus_60cc7026c2fd7.jpeg

Nanodecoys made from human lung spheroid cells (LSCs)
can bind to and neutralize SARS-CoV-2, promoting viral clearance
and reducing lung injury in a macaque model of COVID-19. By
mimicking the receptor that the virus binds to rather than
targeting the virus itself, nanodecoy therapy could remain
effective against emerging variants of the virus.

Leave a Reply

Your email address will not be published. Required fields are marked *

https://nfusion-tech.com/wp-content/uploads/2019/10/Logo_newfusion-footer.png
https://nfusion-tech.com/wp-content/uploads/2019/10/Logo_newfusion-footer.png
Subscribe

If you wish to receive our latest news in your email box, just subscribe to our newsletter. We won’t spam you, we promise!

    New Fusion

    The New Fusion technology is based on a phenomenon called triplet-triplet annihilation (TTA) which is a process in which two triplet excitons annihilate and produce a higher energy singlet exciton.

    Subscribe

    If you wish to receive our latest news in your email box, just subscribe to our newsletter. We won’t spam you, we promise!

      New Fusion

      The New Fusion technology is based on a phenomenon called triplet-triplet annihilation (TTA) which is a process in which two triplet excitons annihilate and produce a higher energy singlet exciton.

      Copyright @2021 New Fusion All Rights Reserved

      Designed by FallingBrick